Associate Principal Scientist
AstraZeneca
Cambridge, United Kingdom
After completing her MSc. in Organic Chemistry with Honours from the University of Milan, Silvia moved to Cambridge in 2011 where she obtained a PhD degree in Chemistry from the University of Cambridge with an emphasis on peptides self-assembly and supramolecular chemistry. In 2015, Silvia joined MedImmune as postdoctoral fellow, where she investigated supramolecular formulation of Antibody-Drug Conjugates. She then joined the Pharmaceutical Sciences department within AstraZeneca in 2017; in this position, she has been working with a broad range of new modalities and different therapeutic areas, with a focus on nanomedicines and long-acting peptide formulations.
The Shift From Passive To Active Targeting Drug Delivery
Monday, October 23, 2023
9:00 AM – 9:30 AM ET
Tuesday, October 24, 2023
1:30 PM – 2:30 PM ET